started · updated
Synthetic opioid crisis drives research into methadone dosing and overdose reversal
The prevalence of high-potency synthetic opioids, such as fentanyl, in the United States drug supply is reshaping approaches to addiction treatment and overdose response. Research published in Health and Quality of Life Outcomes suggests a positive association between higher methadone dosages and improved patient quality of life. Because methadone occupies the same receptors as illicit opioids, maintaining an adequate dose can stabilize patients by reducing cravings and withdrawal symptoms, preventing addiction from disrupting daily life.
Simultaneously, experts are addressing the challenges of reversing overdoses caused by high-potency synthetic opioids (HPSOs). In the year preceding July 2024, over 65,000 opioid overdose fatalities were recorded in the U.S., with 92% involving synthetic opioids excluding methadone. Experts note that the potency and rapid onset of HPSOs increase the risk of re-narcotization. While intranasal naloxone remains widely accessible, researchers are highlighting the potential advantages of prescription intranasal nalmefene, which offers high potency and a longer duration of action to combat the rapid effects of synthetic substances.
Entities
United States · University of Connecticut · Washington University School of Medicine in St. Louis